MTEMQ — Molecular Templates Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$9.66m
- $57.31m
Annual cashflow statement for Molecular Templates, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -69.4 | -105 | -83 | -92.7 | -8.12 |
| Depreciation | |||||
| Non-Cash Items | 28.6 | 15.9 | 18.1 | 13.6 | 3.43 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.4 | 1.3 | 27.9 | -17.3 | -43.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -25.2 | -83.8 | -30.4 | -89 | -41.8 |
| Capital Expenditures | -9.65 | -7.39 | -4 | -3.2 | -0.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.1 | -27.3 | -58.4 | 98.5 | 29.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -39.7 | -34.7 | -62.4 | 95.3 | 29.1 |
| Financing Cash Flow Items | — | — | — | -0.298 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 65.7 | 58.9 | 92.6 | -0.265 | -9.12 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.73 | -59.6 | -0.235 | 6.03 | -21.8 |